Dr Reddy’s, Vodafone Idea, One97 Communications, RBL Bank

[ad_1]

NEW DELHI: Here is the list of actions that could be in the spotlight on Friday:

Dr Reddy’s laboratories: Requested permission from the Indian drug regulator to conduct a Phase 3 clinical trial to assess the efficacy and safety of the Sputnik Light vaccine as a COVID-19 booster dose in India.

Vodafone idea: The phone company was successful in raising funds for the on-time bond interest payment, according to a news report. Vodafone Idea should pay ??6,000 crore from December 13 to March 2022. He has been in talks with lenders and investors to raise funds for the redemption of the bonds.

Aeronautical stocks: India extended the ban on scheduled international flights until January 31. This will not apply to any international all-cargo operations and flights specifically approved by the Director General of Civil Aviation.

One97 Communications: The major fintech subsidiary, Paytm Payments Bank Ltd, has been included in Schedule 2 of the Reserve Bank of India Act and is now a scheduled payments bank. As a result, it can now participate in requests for proposals (RFPs) issued by government and other large companies, primary auctions, fixed and variable rate pensions and reverse pensions, as well as participation in the facility. marginal.

RBL Bank: is looking for buyers for its ??Loan exposure of 105 crore to Future Corporate Resources Pvt Ltd, which owns a controlling stake in Future Coupon, a 51:49 joint venture with Amazon. The decision to sell it comes after a significant delay in the 19-stage two-stage merger Group of the future companies with Future companies, followed by a decline in sales to the entities of the Reliance group.

Ruchi Soya: The Supreme Court has issued opinions to the Securities and Exchange Board of India (Sebi), ESB, NSE and Ruchi Soya asking them to respond to a petition from Kolkata-based Ashav Advisory. The investor claimed that Ruchi failed to honor his pre-Covid pledge to award shares in the company that were worth ??1,700 crores today.

Go fashion: SBI Mutual Fund bought 1.5 million shares of Go Fashion from ??1,172 each through a wholesale transaction on the National Stock Exchange. In another transaction, India Advantage Fund sold 1.5 million shares of Go Fashion to ??1,172 each through a wholesale agreement on the NSE.

HFCL: The company closed the issue of qualified institutional placement and raised ??600 crore by allocating 8 72 72 727 shares at the issue price of ??68.75 each.

Marksans Pharmacy: The British health regulator has granted marketing authorization to the company’s 100% subsidiary, Relonchem, for Loperamide 2 mg capsules. Marksans will manufacture the products at its state-of-the-art MHRA-approved oral dosing facility located in Goa, India.

Trust capital: Deloitte has been chosen to support Nageswara Rao Y, the RBI-appointed administrator for Reliance Capital’s insolvency resolution process, according to a news report. The Deloitte team would help with compliance, filings, communication, and more.

To subscribe to Mint newsletters

* Enter a valid email address

* Thank you for subscribing to our newsletter.

Never miss a story! Stay connected and informed with Mint. Download our app now !!

[ad_2]

Comments are closed.